Abstract
Heart failure (HF) is a complex clinical syndrome whose pathogenesis includes an interplay of neurohormonal and inflammatory processes at the cellular and molecular levels. Oxidative stress (OS) may represent the common pathway for cell death/apoptosis, cardiac remodeling, and dysfunction. There is increasing evidence to indicate that reactive oxygen species (ROS) plays an important role in the development and progression of HF. However, while levels of ROS are elevated in HF, the relative contribution of the different intracellular sources of ROS and the precise mechanisms of this increase remains unclear. Further delineation of the downstream signaling pathways involved in ROS accumulation is important, in order to improve our understanding of these processes and also for the development of new therapies. Indeed, despite previously disappointing results from using antioxidants in human studies, it is likely that modulation of endogenous antioxidants in human HF will continue to have the potential for both, treatment and prevention. In this chapter, we will look at how changes in the cellular redox state of cardiovascular tissue affect the development and progression of HF. In addition, the potential sources of ROS involved in the HF syndrome will be discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Giordano FJ (2005) Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115:500–508
Sohal RS, Svensson I, Sohal BH, Brunk UT (1989) Superoxide anion radical production in different animal species. Mech Ageing Dev 49:129–135
Pryor WA (1986) Oxy-radicals and related species: their formation, lifetimes, and reactions. Annu Rev Physiol 48:657–667
Han D, Antunes F, Canali R, Rettori D, Cadenas E (2003) Voltage-dependent anion channels control the release of the superoxide anion from mitochondria to cytosol. J Biol Chem 278:5557–5563
Wallace DC (2002) Animal models for mitochondrial disease. Methods Mol Biol 197:3–54
Chen Q, Vazquez EJ, Moghaddas S, Hoppel CL, Lesnefsky EJ (2003) Production of reactive oxygen species by mitochondria: central role of complex III. J Biol Chem 278:36027–36031
Herrero A, Barja G (2000) Localization of the site of oxygen radical generation inside the complex I of heart and nonsynaptic brain mammalian mitochondria. J Bioenerg Biomembr 32:609–615
McLennan HR, Degli Esposti M (2000) The contribution of mitochondrial respiratory complexes to the production of reactive oxygen species. J Bioenerg Biomembr 32:153–162
Hellsten-Westing Y (1993) Immunohistochemical localization of xanthine oxidase in human cardiac and skeletal muscle. Histochemistry 100:215–222
Moriwaki Y, Yamamoto T, Suda M, Nasako Y, Takahashi S, Agbedana OE, Hada T, Higashino K (1993) Purification and immunohistochemical tissue localization of human xanthine oxidase. Biochim Biophys Acta 1164:327–330
Cappola TP, Kass DA, Nelson GS, Berger RD, Rosas GO, Kobeissi ZA, Marban E, Hare JM (2001) Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 104:2407–2411
Stadtman ER, Berlett BS (1998) Reactive oxygen-mediated protein oxidation in aging and disease. Drug Metab Rev 30:225–243
Choksi KB, Boylston WH, Rabek JP, Widger WR, Papaconstantinou J (2004) Oxidatively damaged proteins of heart mitochondrial electron transport complexes. Biochim Biophys Acta 1688:95–101
Vasquez-Vivar J, Kalyanaraman B, Kennedy MC (2000) Mitochondrial aconitase is a source of hydroxyl radical. An electron spin resonance investigation. J Biol Chem 275:14064–14069
Petrosillo G, Ruggiero FM, Pistolese M, Paradies G (2001) Reactive oxygen species generated from the mitochondrial electron transport chain induce cytochrome c dissociation from beef-heart submitochondrial particles via cardiolipin peroxidation: possible role in the apoptosis. FEBS Lett 509:435–438
Paradies G, Petrosillo G, Pistolese M, Ruggiero FM (2002) Reactive oxygen species affect mitochondrial electron transport complex I activity through oxidative cardiolipin damage. Gene 286:135–141
Shen Z, Wu W, Hazen SL (2000) Activated leukocytes oxidatively damage DNA, RNA, and the nucleotide pool through halide-dependent formation of hydroxyl radical. Biochemistry 39:5474–5482
LeDoux SP, Wilson GL (2001) Base excision repair of mitochondrial DNA damage in mammalian cells. Prog Nucleic Acid Res Mol Biol 68:273–284
Yakes FM, Van Houten B (1997) Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA 94:514–519
Brown GC (1999) Nitric oxide and mitochondrial respiration. Biochim Biophys Acta 1411:351–369
Riobo NA, Clementi E, Melani M, Boveris A, Cadenas E, Moncada S, Poderoso JJ (2001) Nitric oxide inhibits mitochondrial NADH:ubiquinone reductase activity through peroxynitrite formation. Biochem J 359:139–145
Murray J, Taylor SW, Zhang B, Ghosh SS, Capaldi RA (2003) Oxidative damage to mitochondrial complex I due to peroxynitrite: identification of reactive tyrosines by mass spectrometry. J Biol Chem 278:37223–37230
Cassina AM, Hodara R, Souza JM, Thomson L, Castro L, Ischiropoulos H, Freeman BA, Radi R (2000) Cytochrome c nitration by peroxynitrite. J Biol Chem 275:21409–21415
Castro L, Rodriguez M, Radi R (1994) Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J Biol Chem 269:29409–29415
Packer MA, Scarlett JL, Martin SW, Murphy MP (1997) Induction of the mitochondrial permeability transition by peroxy-nitrite. Biochem Soc Trans 25:909–914
Brookes PS, Darley-Usmar VM (2004) Role of calcium and superoxide dismutase in sensitizing mitochondria to peroxynitrite-induced permeability transition. Am J Physiol Heart Circ Physiol 286:H39–H46
Nemoto S, Takeda K, Yu ZX, Ferrans VJ, Finkel T (2000) Role for mitochondrial oxidants as regulators of cellular metabolism. Mol Cell Biol 20:7311–7318
Cadenas E (2004) Mitochondrial free radical production and cell signaling. Mol Aspects Med 25:17–26
Bogoyevitch MA, Ng DC, Court NW, Draper KA, Dhillon A, Abas L (2000) Intact mitochondrial electron transport function is essential for signalling by hydrogen peroxide in cardiac myocytes. J Mol Cell Cardiol 32:1469–1480
Archer SL, Wu XC, Thebaud B, Moudgil R, Hashimoto K, Michelakis ED (2004) O2 sensing in the human ductus arteriosus: redox-sensitive K+ channels are regulated by mitochondria-derived hydrogen peroxide. Biol Chem 385:205–216
Yamamura T, Otani H, Nakao Y, Hattori R, Osako M, Imamura H, Das DK (2001) Dual involvement of coenzyme Q10 in redox signaling and inhibition of death signaling in the rat heart mitochondria. Antioxid Redox Signal 3:103–112
Brookes PS, Levonen AL, Shiva S, Sarti P, Darley-Usmar VM (2002) Mitochondria: regulators of signal transduction by reactive oxygen and nitrogen species. Free Radic Biol Med 33:755–764
Boveris A, D’Amico G, Lores-Arnaiz S, Costa LE (2003) Enalapril increases mitochondrial nitric oxide synthase activity in heart and liver. Antioxid Redox Signal 5:691–697
Hess ML, Manson NH (1984) Molecular oxygen: friend and foe. The role of the oxygen free radical system in the calcium paradox, the oxygen paradox and ischemia/reperfusion injury. J Mol Cell Cardiol 16:969–985
Becker LB (2004) New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 61:461–470
Becker LB, vanden Hoek TL, Shao ZH, Li CQ, Schumacker PT (1999) Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am J Physiol 277:H2240–H2246
Marin-Garcia J, Goldenthal MJ, Moe GW (2001) Abnormal cardiac and skeletal muscle mitochondrial function in pacing-induced cardiac failure. Cardiovasc Res 52:103–110
Moe GW, Marin-Garcia J, Konig A, Goldenthal M, Lu X, Feng Q (2004) In vivo tumor necrosis factor alpha inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress and apoptosis in experimental heart failure. Am J Physiol Heart Circ Physiol 287:H1813–H1820
Ide T, Tsutsui H, Kinugawa S et al (2000) Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ Res 6:152–157
Ide T, Tsutsui H, Kinugawa S, Utsumi H et al (1999) Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res 85:357–363
Marin-Garcia J, Goldenthal MJ, Ananthakrishnan R, Mirvis D (1996) Specific mitochondrial DNA deletions in canine myocardial ischemia. Biochem Mol Biol Int 40:1057–1065
Suematsu N, Tsutsui H, Wen J et al (2003) Oxidative stress mediates tumor necrosis factor-alpha-induced mitochondrial DNA damage and dysfunction in cardiac myocytes. Circulation 107:1418–1423
Ide T, Tsutsui H, Hayashidani S et al (2001) Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res 88:529–535
Tsutsui H, Kinugawa S, Matsushima S (2009) Mitochondrial oxidative stress and dysfunction in myocardial remodeling. Cardiovasc Res 81:449–456
Sorescu D, Griendling K (2002) Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure. Congest Heart Fail 8:132–140
Griendling KK, Sorescu D, Ushio-Fukai M (2000) NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86:494–501
Sabri A, Hughie HH, Lucchesi PA (2003) Regulation of hyper-trophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes. Antioxid Redox Signal 5:731–740
Li JM, Gall NP, Grieve DJ, Chen M, Shah AM (2002) Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension 40:477–484
Xiao L, Pimentel DR, Wang J, Singh K, Colucci WS, Sawyer DB (2002) Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes. Am J Physiol Cell Physiol 282:C926–C934
Heymes C, Bendall JK, Ratajczak P, Cave AC, Samuel JL, Hasenfuss G, Shah AM (2003) Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol 41:2164–2171
Nakagami H, Liao JK (2004) Statins and myocardial hypertrophy. Coron Artery Dis 15:247–250
Maack C, Kartes T, Kilter H, Schafers HJ, Nickenig G, Bohm M, Laufs U (2003) Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment. Circulation 108:1567–1574
Ferrari R, Guardigli G, Mele D, Percoco GF, Ceconi C, Curello S (2004) Oxidative stress during myocardial ischaemia and heart failure. Curr Pharm Des 10:1699–1711
Ijsselmuiden AJ, Musters RJ, de Ruiter G et al (2008) Circulating white blood cells and platelets amplify oxidative stress in heart failure. Nat Clin Pract Cardiovasc Med 5:811–820
Witztum JL, Steinberg D (1991) Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88:1785–1792
Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS (1996) Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 98:2572–2579
Khatri JJ, Johnson C, Magid R et al (2004) Vascular oxidant stress enhances progression and angiogenesis of experimental atheroma. Circulation 109:520–525
Malinski T (2005) Understanding nitric oxide physiology in the heart: a nanomedical approach. Am J Cardiol 96:13i–24i
Ungvari Z, Gupte SA, Recchia FA, Batkai S, Pacher P (2005) Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure. Curr Vasc Pharmacol 3:221–229
Hare JM, Stamler JS (2005) NO/redox disequilibrium in the failing heart and cardiovascular system. J Clin Invest 115:509–517
Martinez-Ruiz A, Lamas S (2004) S-nitrosylation: a potential new paradigm in signal transduction. Cardiovasc Res 62:43–52
Lodi R, Tonon C, Calabrese V, Schapira AH (2006) Friedreich’s ataxia: from disease mechanisms to therapeutic interventions. Antioxid Redox Signal 8:438–443
Kaneto H, Katakami N, Kawamori D et al (2007) Involvement of oxidative stress in the pathogenesis of diabetes. Antioxid Redox Signal 9:355–366
Cave AC, Brewer AC, Narayanapanicker A, Ray R, Grieve DJ, Walker S, Shah AM (2006) NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 8:691–728
Lucas DT, Szweda LI (1998) Cardiac reperfusion injury: aging, lipid peroxidation, and mitochondrial dysfunction. Proc Natl Acad Sci USA 95:510–514
Nohl H, Hegner D (1978) Do mitochondria produce oxygen radicals in vivo? Eur J Biochem 82:563–567
Sohal RS, Arnold LA, Sohal BH (1990) Age-related changes in antioxidant enzymes and prooxidant generation in tissues of the rat with special reference to parameters in two insect species. Free Radic Biol Med 9:495–500
Yan LJ, Sohal RS (1998) Mitochondrial adenine nucleotide translocase is modified oxidatively during aging. Proc Natl Acad Sci USA 95:12896–12901
Nohl H, Kramer R (1980) Molecular basis of age-dependent changes in the activity of adenine nucleotide translocase. Mech Aging Dev 14:137–144
Kim JH, Shrago E, Elson CE (1988) Age-related changes in respiration coupled to phosphorylation. II. Cardiac mitochondria. Mech Aging Dev 46:279–290
Kim JH, Woldgiorgis G, Elson CE, Shrago E (1988) Age-related changes in respiration coupled to phosphorylation. I. Hepatic mitochondria. Mech Aging Dev 46:263–277
Hashimoto M, Majima E, Goto S, Shinohara Y, Terada H (1999) Fluctuation of the first loop facing the matrix of the mitochondrial ADP/ATP carrier deuced from intermolecular cross linking of Cys56 residues by bifunctional dimaleimides. Biochemistry 38:1050–1056
Yokozawa T, Satoh A, Cho EJ (2004) Ginsenoside-Rd attenuates oxidative damage related to aging in senescence-accelerated mice. J Pharm Pharmacol 56:107–113
Zhu Y, Carvey PM, Ling Z (2006) Age-related changes in glutathione and glutathione-related enzymes in rat brain. Brain Res 1090:35–44
Judge S, Jang YM, Smith A, Hagen T, Leeuwenburgh C (2005) Age-associated increases in oxidative stress and antioxidant enzyme activities in cardiac interfibrillar mitochondria: implications for the mitochondrial theory of aging. FASEB J 19:419–421
Suh JH, Heath SH, Hagen TM (2003) Two subpopulations of mitochondria in the aging rat heart display heterogenous levels of oxidative stress. Free Radic Biol Med 5:1064–1072
Mo JQ, Hom DG, Andersen JK (1995) Decreases in protective enzymes correlates with increased oxidative damage in the aging mouse brain. Mech Aging Dev 81:73–78
Chen JJ, Bertrand H, Yu BP (1995) Inhibition of adenine nucleotide translocator by lipid peroxidation products. Free Radic Biol Med 19:583–590
Pepe S (2005) Effect of dietary polyunsaturated fatty acids on age-related changes in cardiac mitochondrial membranes. Exp Gerontol 40:751–758
Kristal BS, Park BK, Yu BP (1996) 4-Hydroxyhexenal is a potent inducer of the mitochondrial permeability transition. J Biol Chem 271:6033–6038
Hansford RG, Castro F (1982) Effect of senescence on Ca-ion transport by heart mitochondria. Mech Aging Dev 19:5–13
Beckman JS, Koppenol WH (1996) Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 9:836–844
Kanski J, Behring A, Pelling J, Schoneich C (2005) Proteomic identification of 3- nitrotyrosine-containing rat cardiac proteins: effects of biological aging. Am J Physiol 288:H371–H381
Turko IV, Li L, Aulak KS, Stuehr DJ, Chang JY, Murad F (2003) Protein tyrosine nitration in the mitochondria from diabetic mouse heart. Implications to dysfunctional mitochondria in diabetes. J Biol Chem 278:33972–33977
Madesh M, Hajnoczky G (2001) VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release. J Cell Biol 155:1003–1015
Hoffman B, Stockl A, Schame M, Beyer K, Klingenberg M (1994) Reconstituted ADP/ATP carrier has an absolute requirement for cardiolipin as shown in cysteine mutants. J Biol Chem 269:1940–1949
Nehal M, Azam M, Baquer NZ (1990) Changes in the levels of catecholamines, hexokinase and glucose 6-phosphate dehydrogenase in red cell aging. Biochem Int 22:517–522
Kanski J, Schoneich C (2005) Protein nitration in biological aging: proteomic and tandem mass spectrometric characterization of nitrated sites. Methods Enzymol 396:160–171
Pastoris O, Boschi F, Verri M, Baiardi P, Felzani G, Vecchiet J, Dossena M, Catapano M (2000) The effects of aging on enzyme activities and metabolite concentrations in skeletal muscle from sedentary male and female subjects. Exp Gerontol 35:95–104
Kannan K, Jain SK (2000) Oxidative stress and apoptosis. Pathophysiology 7:153–163
Keller JN, Kindy MS, Holtsberg FW et al (1998) Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J Neurosci 18:687–697
Shiomi T, Tsutsui H, Matsusaka H et al (2004) Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation 109: 544–549
Kang YJ, Zhou ZX, Wu H, Wang GW, Saari JT, Klein JB (2000) Metallothionein inhibits myocardial apoptosis in copper-deficient mice: role of atrial natriuretic peptide. Lab Invest 80:745–757
Lud Cadet J, Harrington B, Ordonez S (2000) Bcl-2 overexpression attenuates dopamine-induced apoptosis in an immortalized neural cell line by suppressing the production of reactive oxygen species. Synapse 35:228–233
Kokoszka JE, Coskun P, Esposito LA, Wallace DC (2001) Increased mitochondrial oxidative stress in the Sod2 (+/-) mouse results in the age-related decline of mitochondrial function culminating in increased apoptosis. Proc Natl Acad Sci USA 98:2278–2283
Fu Y, Porres JM, Lei XG (2001) Comparative impacts of glutathione peroxidase-1 gene knockout on oxidative stress induced by reactive oxygen and nitrogen species in mouse hepatocytes. Biochem J 359:687–695
Goossens V, Stange G, Moens K, Pipeleers D, Grooten J (1999) Regulation of tumor necrosis factor-induced, mitochondria- and reactive oxygen species-dependent cell death by electron flux through electron transport chain complex I. Antioxid Redox Signal 1:285–295
von Harsdorf R, Li PF, Dietz R (1999) Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation 99:2934–2941
Akao M, O’Rourke B, Teshima Y, Seharaseyon J, Marban E (2003) Mechanistically distinct steps in the mitochondrial death pathway triggered by oxidative stress in cardiac myocytes. Circ Res 92:186–194
Long X, Goldenthal MJ, Wu GM, Marin-Garcia J (2004) Mitochondrial Ca2+ flux and respiratory enzyme activity decline are early events in cardiomyocyte response to H(2)O(2). J Mol Cell Cardiol 37:63–70
Hickson-Bick DL, Sparagna GC, Buja LM, McMillin JB (2002) Palmitate-induced apoptosis in neonatal cardiomyocytes is not dependent on the generation of ROS. Am J Physiol Heart Circ Physiol 282:H656–H664
Elahi MM, Naseem KM, Matata BM (2007) Nitric oxide in blood. The nitrosative-oxidative disequilibrium hypothesis on the pathogenesis of cardiovascular disease. FEBS J 274:906–923
Sharma R, Davidoff MN (2002) Oxidative stress and endothelial dysfunction in heart failure. Congest Heart Fail 8:165–172
Ungvári Z, Gupte SA, Recchia FA, Bátkai S, Pacher P (2005) Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure. Curr Vasc Pharmacol 3:221–229
Chen Y, Saari JT, Kang YJ (1994) Weak antioxidant defenses make the heart a target for damage in copper-deficient rats. Free Radic Biol Med 17:529–536
Radi R, Turrens JF, Chang LY, Bush KM, Crapo JD, Freeman BA (1991) Detection of catalase in rat heart mitochondria. J Biol Chem 266:22028–22034
Antunes F, Han D, Cadenas E (2002) Relative contributions of heart mitochondria glutathione peroxidase and catalase to H2O2 detoxification in in vivo conditions. Free Radic Biol Med 33:1260–1267
Phung CD, Ezieme JA, Turrens JF (1994) Hydrogen peroxide metabolism in skeletal muscle mitochondria. Arch Biochem Biophys 315:479–482
Judge S, Judge A, Grune T, Leeuwenburgh C (2004) Short-term CR decreases cardiac mitochondrial oxidant production but increases carbonyl content. Am J Physiol Regul Integr Comp Physiol 286:R254–R259
Turko IV, Murad F (2003) Quantitative protein profiling in heart mitochondria from diabetic rats. J Biol Chem 278:35844–35849
Radi R, Bush KM, Freeman BA (1993) The role of cytochrome c and mitochondrial catalase in hydroperoxide-induced heart mitochondrial lipid peroxidation. Arch Biochem Biophys 300:409–415
Zhou Z, Kang YJ (2000) Cellular and subcellular localization of catalase in the heart of transgenic mice. J Histochem Cytochem 48:585–594
Fernandez-Checa JC, Garcia-Ruiz C, Colell A, Morales A, Mari M, Miranda M, Ardite E (1998) Oxidative stress: role of mitochondria and protection by glutathione. Biofactors 8:7–11
Vaage J, Antonelli M, Bufi M et al (1997) Exogenous reactive oxygen species deplete the isolated rat heart of antioxidants. Free Radic Biol Med 22:85–92
Hasinoff BB, Schnabl KL, Marusak RA, Patel D, Huebner E (2003) Dexrazoxane protects cardiac myocytes against doxorubicin by preventing damage to mitochondria. Cardiovasc Toxicol 3:89–99
Lipshultz SE, Rifai N, Dalton VM, Levy DE et al (2004) The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. N Engl J Med 351:145–153
Kang YJ (1999) The antioxidant function of metallothionein in the heart. Proc Soc Exp Biol Med 222:263–273
Nath R, Kumar D, Li T, Singal PK (2000) Metallothioneins, oxidative stress and the cardiovascular system. Toxicology 155:17–26
Ali MM, Frei E, Straub J, Breuer A, Wiessler M (2002) Induction of metallothionein by zinc protects from daunorubicin toxicity in rats. Toxicology 179:85–93
Okuda M, Lee HC, Kumar C, Chance B (1992) Comparison of the effect of a mitochondrial uncoupler, 2, 4-dinitrophenol and adrenaline on oxygen radical production in the isolated perfused rat liver. Acta Physiol Scand 145:159–168
Korshunov SS, Korkina OV, Ruuge EK, Skulachev VP, Starkov AA (1998) Fatty acids as natural uncouplers preventing generation of O2- and H2O2 by mitochondria in the resting state. FEBS Lett 435:215–218
Casteilla L, Rigoulet M, Penicaud L (2001) Mitochondrial ROS metabolism: modulation by uncoupling proteins. IUBMB Life 52:181–188
Papa S, Skulachev VP (1997) Reactive oxygen species, mitochondria, apoptosis and aging. Mol Cell Biochem 174:305–319
Vidal-Puig AJ, Grujic D, Zhang CY et al (2000) Energy metabolism in uncoupling protein 3 gene knockout mice. J Biol Chem 275:16258–16266
Hoerter J, Gonzalez-Barroso MD, Couplan E et al (2004) Mitochondrial uncoupling protein 1 expressed in the heart of transgenic mice protects against ischemic-reperfusion damage. Circulation 110:528–533
Teshima Y, Akao M, Jones SP, Marban E (2003) Uncoupling protein-2 overexpression inhibits mitochondrial death pathway in cardiomyocytes. Circ Res 93:192–200
Pacher P, Liaudet L, Mabley JG, Cziráki A, Haskó G, Szabó C (2006) Beneficial effects of a novel ultrapotent poly(ADP-ribose) polymerase inhibitor in murine models of heart failure. Int J Mol Med 17:369–375
Cooper JM, Schapira AH (2003) Friedreich’s ataxia: disease mechanisms, antioxidant and Coenzyme Q10 therapy. Biofactors 18:163–171
Santos DL, Moreno AJ, Leino RL, Froberg MK, Wallace KB (2002) Carvedilol protects against doxorubicin-induced mitochondrial cardiomyopathy. Toxicol Appl Pharmacol 185:218–227
Lerman-Sagie T, Rustin P, Lev D et al (2001) Dramatic improvement in mitochondrial cardiomyopathy following treatment with idebenone. J Inherit Metab Dis 24:28–34
Sayed-Ahmed M, Salman T, Gaballah H, Abou El-Naga SA, Nicolai R, Calvani M (2001) Propionyl-L-carnitine as protector against adriamycin-induced cardiomyopathy. Pharmacol Res 43:513–520
Shite J, Qin F, Mao W, Kawai H, Stevens SY, Liang C (2001) Antioxidant vitamins attenuate oxidative stress and cardiac dysfunction in tachycardia-induced cardiomyopathy. J Am Coll Cardiol 38:1734–1740
Geromel V, Darin N, Chretien D, Benit P, DeLonlay P, Rotig A, Munnich A, Rustin P (2002) Coenzyme Q(10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits. Mol Genet Metab 77:21–30
Hausse AO, Aggoun Y, Bonnet D, Sidi D, Munnich A, Rotig A, Rustin P (2002) Idebenone and reduced cardiac hypertrophy in Friedreich’s ataxia. Heart 87:346–349
Rustin P, Munnich A, Rotig A (1999) Quinone analogs prevent enzymes targeted in Friedreich ataxia from iron-induced injury in vitro. Biofactors 9:247–251
Lerman-Sagie T, Rustin P, Lev D, Yanoov M, Leshinsky-Silver E, Sagie A, Ben-Gal T, Munnich A (2001) Dramatic improvement in mitochondrial cardiomyopathy following treatment with idebenone. J Inherit Metab Dis 24:28–34
Shoffner JM, Wallace DC (1994) Oxidative phosphorylation diseases and mitochondrial DNA mutations: diagnosis and treatment. Annu Rev Nutr 14:535–568
Ogasahara S, Yorifuji S, Nishikawa Y et al (1985) Improvement of abnormal pyruvate metabolism and cardiac conduction defect with coenzyme Q10 in Kearns-Sayre syndrome. Neurology 35:372–377
Mortensen SA, Vadhanavikit S, Baandrup U, Folkers K (1985) Long-term coenzyme Q10 therapy: a major advance in the management of resistant myocardial failure. Drugs Exp Clin Res 11:581–593
Hargreaves IP (2003) Ubiquinone: cholesterol’s reclusive cousin. Ann Clin Biochem 40:207–218
Mortensen SA (2003) Overview on coenzyme Q10 as adjunctive therapy in chronic heart failure: rationale, design and end-points of “Q-symbio” a multinational trial. Biofactors 18:79–89
Castro P, Vukasovic JL, Chiong M et al (2005) Effects of carvedilol on oxidative stress and chronotropic response to exercise in patients with chronic heart failure. Eur J Heart Fail 7: 1033–1039
Chin BS, Gibbs CR, Blann AD, Lip GY (2003) Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection. Clin Sci (Lond) 105:507–512
Nakamura K, Kusano K, Nakamura Y et al (2002) Carvedilol decreases elevated oxidative stress in human failing myocardium. Circulation 105:2867–2871
Kono Y, Nakamura K, Kimura H et al (2006) Elevated levels of oxidative DNA damage in serum and myocardium of patients with heart failure. Circ J 70:1001–1005
Chin BS, Langford NJ, Nuttall SL, Gibbs CR, Blann AD, Lip GY (2003) Anti-oxidative properties of beta-blockers and angiotensin-converting enzyme inhibitors in congestive heart failure. Eur J Heart Fail 5:171
Bauersachs J, Widder JD (2008) Endothelial dysfunction in heart failure. Pharmacol Rep 60:119–126
Bauersachs J, Schäfer A (2004) Endothelial dysfunction in heart failure: mechanisms and therapeutic approaches. Curr Vasc Pharmacol 2:115–124
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Marín-García, J. (2010). Oxidative Stress and Heart Failure. In: Heart Failure. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-147-9_10
Download citation
DOI: https://doi.org/10.1007/978-1-60761-147-9_10
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-146-2
Online ISBN: 978-1-60761-147-9
eBook Packages: MedicineMedicine (R0)